
Bavarian Nordic shares rise 7% following strong Q1 for vaccine sales
Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from the same period in 2024. The Danish vaccine specialist reported quarterly revenue of DKr1.3bn ($200m), a 62% year-over-year …